Abcm Corporation (ABCM): Price and Financial Metrics Recent IPO


Abcm Corporation (ABCM): $22.92

0.33 (+1.46%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

ABCM Stock Price Chart Interactive Chart >

Price chart for ABCM

ABCM Price/Volume Stats

Current price $22.92 52-week high $24.69
Prev. close $22.59 52-week low $17.71
Day low $22.22 Volume 229,314
Day high $22.98 Avg. volume 168,818
50-day MA $22.29 Dividend yield N/A
200-day MA $0.00 Market Cap 5.20B

Abcm Corporation (ABCM) Company Bio


Abcm Corporation operates rehabilitation centers, long-term care facilities, and independent and assisted living communities. The Company offers out-patient therapy, independent and assisted living, skilled nursing and rehabilitative care, dementia care, family respite care, respite services, and home care. ABCM serves patients throughout the United States.


ABCM Latest News Stream


Event/Time News Detail
Loading, please wait...

ABCM Latest Social Stream


Loading social stream, please wait...

View Full ABCM Social Stream

Latest ABCM News From Around the Web

Below are the latest news stories about Abcam plc that investors may wish to consider to help them evaluate ABCM as an investment opportunity.

World Outlook for the Research Antibodies Market to 2027, Featuring Key Players Lonza Group, Agilent Technologies, Dickinson and Company, Abcam PLC, Bio-Rad Laboratories and More

DUBLIN, Feb. 19, 2021 /PRNewswire/ -- The "Research Antibodies Market By Product, By Antibody Type, By Technology, By Application, By End-Users, 2017-2027" report has been added to ResearchAndMarkets.com's offering. A significant rise in research activities in the field of stem cells and…

PR Newswire | February 19, 2021

Abcam to present at the 2021 SVB Leerink Global Healthcare Conference

CAMBRIDGE, United Kingdom, Feb. 17, 2021 (GLOBE NEWSWIRE) -- Abcam plc (Nasdaq: ABCM; LSE: ABC) today announced that Alan Hirzel, Chief Executive Officer, will present at the 2021 SVB Leerink Global Healthcare Conference on Friday, February 26, 2021 at 8.00 EST / 13.00 GMT. A live webcast of the presentation can be accessed via the IR Calendar page of Abcam’s Investor Relations website at https://www.abcamplc.com/reports-presentations. Contact: James Staveley, VP, Investor [email protected]+44 (0) 1223 392 948 About Abcam plcAs an innovator in reagents and tools, Abcam's purpose is to serve life science researchers globally to achieve their mission, faster. Providing the research and clinical communities with tools and scientific support, the Company offers highly valida...

Yahoo | February 17, 2021

Custom Antibody Market 2021 - 2027 Key segments analysis, Size, Industry Share, Growth, Future Trends, Top Key Players Thermo Fisher Scientific Inc., Merck Group, Bio-Rad Laboratories, Inc., Abcam

The global custom antibody market is expected to grow in the upcoming years. Custom antibody has high specificity and selectivity. As compared to other antibodies the custom antibodies can be easily produced. Download Free Sample [email protected] https://www.alliedmarketresearch.com/request-sample/4260 Custom Antibody Market Report

OpenPR | February 12, 2021

COVID-19 rapid test firm Abingdon Health signs collaboration agreement

Abingdon Health has signed a collaboration and co-marketing agreement with Abcam, a global leader in the supply of life science research tools and reagents.

Yorkshire Post | February 9, 2021

Worldwide CRISPR Gene Editing Industry to 2030 - Players Include Abcam, Applied StemCell and Agilent Technologies Among Others

DUBLIN, Feb. 9, 2021 /PRNewswire/ -- The "Global CRISPR Gene Editing Market: Focus on Products, Applications, End Users, Country Data (16 Countries), and Competitive Landscape - Analysis and Forecast, 2020-2030" report has been added to ResearchAndMarkets.com's offering. The global CRISPR…

PR Newswire | February 9, 2021

Read More 'ABCM' Stories Here

ABCM Price Returns

1-mo -0.91%
3-mo 18.88%
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD 6.36%
2020 N/A
2019 N/A
2018 N/A
2017 N/A
2016 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!

Page generated in 0.6357 seconds.